Boston ScientificMEX:BSX -1.65%85 Market Cap is MXN1,151,680 Mil as of Jun. 29, 2026. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,852.47 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 867 Medical Devices & Instruments companies, Boston Scientific ranks better than 99.31% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Boston Scientific's share price for the quarter that ended in Mar. 2026 was MXN1119.69. Boston Scientific's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,486 Mil. Therefore, Boston Scientific's market cap for the quarter that ended in Mar. 2026 was MXN1,664,189 Mil.
Boston Scientific's quarterly market cap
declined
from Sep. 2025 (MXN2,650,322 Mil) to Dec. 2025 (MXN2,550,790 Mil) and
declined
from Dec. 2025 (MXN2,550,790 Mil) to Mar. 2026 (MXN1,664,189 Mil).
Boston Scientific's annual market cap
increased
from Dec. 2023 (MXN1,391,003 Mil) to Dec. 2024 (MXN2,713,183 Mil) but then
declined
from Dec. 2024 (MXN2,713,183 Mil) to Dec. 2025 (MXN2,550,790 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Boston Scientific's Enterprise Value for Today is MXN1,323,578 Mil.
Boston Scientific (MEX:BSX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Boston Scientific Market Cap Related Terms
Boston Scientific Market Cap Historical Data
* Premium members only.
The historical data trend for Boston Scientific's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Boston Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Market Cap distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Boston Scientific's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) has a Market Cap of MXN1,151,680 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Boston Scientific and its competitors. According to the industry distribution chart, Boston Scientific ranks #6 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 0.7%.
Is Boston Scientific's Market Cap too high?
Boston Scientific's current Market Cap is MXN1,151,680 Mil. Based on the distribution chart, Boston Scientific ranks #6 out of 867 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Market Cap compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #6 out of 867 companies for Market Cap. This places Boston Scientific in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 117.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 117.03, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Boston Scientific and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 117.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boston Scientific's current Market Cap is MXN1,151,680 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,852.47, compared to a current price of MXN777.00 — trading 58.1% below its estimated fair value. The current Market Cap is MXN1,151,680 Mil. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Market Cap is MXN1,151,680 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (MEX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of MXN777.00 is trading 58.1% below its estimated GF Value™ of MXN1,852.47.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for MEX:BSX:
Market Cap: MXN1,151,680 Mil
GF Value™: MXN1,852.47 vs. price of MXN777.00 (58.1% below fair value)
No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score
Get the complete analysis for MEX:BSX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BSX has been successfully added to your 
